Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Liver function markers predict cardiovascular and renal outcomes in the CANVAS Program

Fig. 2

Multivariate Cox proportional hazards model of the association of updated LFTs, risk markers and canagliflozin treatment with incident hospitalized HF (left) and renal outcome (right). M male sex; SD standard deviation; BMI body mass index; T2D type 2 diabetes; eGFR estimated glomerular filtration rate; SBP systolic blood pressure; HDL high-density lipoprotein cholesterol; LDL low density lipoprotein cholesterol; CV cardiovascular; HF heart failure; RAASi renin angiotensin aldosterone system inhibitors; ALT alanine aminotransferase; AST aspartic aminotransferase; ALP alkaline phosphatase; gGT gamma-glutamyl transferase

Back to article page